CHIMERIC ANTIGEN RECEPTOR-T CELLS DERIVED EXTRACELLULAR VESICLES AS A POTENTIAL CANCER THERAPY

被引：0
|
作者：
Horn, G. [1 ]
Aharon, A. [2 ]
Bar-Lev, T. Hana [2 ]
Yohay, E. Zagagi [2 ]
Waks, T. [1 ]
Levin, M. [2 ]
Unger, N. Deshet [1 ]
Avivi, I. [2 ]
Levin, A. Globerson [1 ]
机构：
[1] Ichilov Tel Aviv Med Ctr, Immunotherapy Lab, Tel Aviv, Israel
[2] Ichilov Tel Aviv Med Ctr, Hematol Lab, Tel Aviv, Israel
来源：
HUMAN GENE THERAPY | 2022年 / 33卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P030
引用
收藏
页码：A24 / A24
页数：1
相关论文
共 50 条
  • [41] Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer
    Yu Cao
    Sergey K. Efetov
    Mingze He
    Yu Fu
    Narasimha M. Beeraka
    Jin Zhang
    Xinliang Zhang
    Namitha Bannimath
    Kuo Chen
    Archivum Immunologiae et Therapiae Experimentalis, 2023, 71
  • [42] Chimeric Antigen Receptor-T Cells in the Modern Era of Chronic Lymphocytic Leukemia Treatment
    Hatashima, Alycia
    Shadman, Mazyar
    Raghunathan, Vikram
    CANCERS, 2025, 17 (02)
  • [43] Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
    Xiao Han
    Yao Wang
    Jianshu Wei
    Weidong Han
    Journal of Hematology & Oncology, 12
  • [44] Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
    Han, Xiao
    Wang, Yao
    Wei, Jianshu
    Han, Weidong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [45] Chimeric antigen receptor-T cell therapies: The changing landscape
    Sengsayadeth, Salyka M.
    Dholaria, Bhagirathbhai R.
    Savani, Bipin N.
    Oluwole, Olalekan O.
    EJHAEM, 2022, 3 : 3 - 5
  • [46] Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain, Cindy
    Boulch, Morgane
    Bousso, Philippe
    Allanore, Yannick
    Avouac, Jerome
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (11) : 1954 - 1965
  • [47] Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy
    Hensel, Jonathan
    Metts, Jonathan
    Gupta, Ajay
    Ladle, Brian H.
    Pilon-Thomas, Shari
    Mullinax, John
    CANCER JOURNAL, 2022, 28 (04): : 322 - 327
  • [48] Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
    Tao, Kelong
    He, Meng
    Tao, Feng
    Xu, Guangen
    Ye, Minfeng
    Zheng, Yuanyuan
    Li, Yaoqing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 815 - 827
  • [49] Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
    Kelong Tao
    Meng He
    Feng Tao
    Guangen Xu
    Minfeng Ye
    Yuanyuan Zheng
    Yaoqing Li
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 815 - 827
  • [50] Cardiovascular Complications of CD 19 Chimeric Antigen Receptor-T Cell Therapy: A Systematic Review
    Shahzad, Moazzam
    Munir, Farrukh
    Khan, Junaid
    Khalid, Muhammad Fareed
    Abbas, Sakina
    Javaid, Hafiza Wajeeha
    Chattha, Suneeba Javed
    Ahmed, Mamoon
    Faisal, Muhammad Salman
    Anwar, Iqra
    Chaudhary, Sibgha Gull
    Mushtaq, Muhammad Umair
    BLOOD, 2022, 140 : 12768 - 12769
12345